Vasorelaxant activity of some oxime derivatives

European Journal of Pharmacology

Volumn 575, Issue 1-3, 2007, Pages 122-126

  Jaroš, Filip ^a   Straka, Tomáš ^a   Dobešová, Zdenka ^b   Pintérová, Mária ^b   Chalupský, Karel ^a   Kuneš, Jaroslav ^b   Entlicher, Gustav ^a   Zicha, Josef ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Acetohydroxamic acid; Blood pressure; Formaldoxime; Formamidoxime; NO dependent vasodilation; NO independent vasodilation

Indexed keywords

ACETALDOXIME; ACETOHYDROXAMIC ACID; ACETOXIME; CAPTOPRIL; FORMALDOXIME; FORMAMIDE OXIME; GLYCERYL TRINITRATE; HYDROXYUREA; METHYLENE BLUE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; OXIME DERIVATIVE; PENTOLONIUM TARTRATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; HYDROPHILICITY; HYDROPHOBICITY; IN VIVO STUDY; MALE; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; RAT; VASODILATATION; WISTAR RAT;

ANIMALS; AORTA; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HYDROPHOBICITY; HYDROXAMIC ACIDS; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; OXIMES; PENTOLINIUM TARTRATE; RATS; RATS, WISTAR; VASODILATION; VASODILATOR AGENTS;

EID: 35348837185     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.07.040     Document Type: Article

References (26)

1. Andronik-Lion V., Boucher J.L., Delaforge M., Henry Y., and Mansuy D. Formation of nitric oxide by cytochrome P450-catalyzed oxidation of aromatic amidoximes. Biochem. Biophys. Res. Commun. 185 (1992) 452-458
2. 2 to nitric oxide and citrulline. Biochem. Biophys. Res. Commun. 187 (1992) 880-886
3. w-hydroxy-l-arginine by hemoproteins. Biochem. Biophys. Res. Commun. 184 (1992) 1158-1164
4. Caro A.A., Cederbaum A.I., and Stoyanovsky D.A. Oxidation of the ketoxime acetoxime to nitric oxide by oxygen radical-generating systems. Nitric Oxide 5 (2001) 413-424
5. Chalupský K., Lobysheva I., Nepveu F., Gadea I., Beranová P., Entlicher G., Stoclet J.C., and Muller B. Relaxant effect of oxime derivatives in isolated rat aorta: role of nitric oxide (NO) formation in smooth muscle. Biochem. Pharmacol. 67 (2004) 1203-1214
6. Clement B., Schultze-Mosgau M.H., and Wohlers H. Cytochrome P450 dependent N-hydroxylation of a guanidine (debrisoquine), microsomal catalysed reduction and further oxidation of the N-hydroxyguanidine metabolite to the urea derivative. Similarity with the oxidation of arginine to citrulline and nitric oxide. Biochem. Pharmacol. 46 (1993) 2249-2267
7. Frear D.S., and Burrell R.C. Spectrometric method for determining hydroxylamine reductase activity in higher plants. Anal. Biochem. 27 (1955) 1664-1665
8. Hansch C., Leo A., and Hoekman D. Exploring QSAR hydrophobic, electronic and steric constants. ACS Professional Reference Book (1995), Am. Chem. Soc., Washington, DC.
9. Jia Y., Zacour M., Tolloczko B., and Martin J.G. Nitric oxide synthesis by tracheal smooth muscle cells by a nitric oxide synthase-independent pathway. Am. J. Physiol. 275 (1998) L895-L901
10. Jousserandot A., Boucher J.L., Henry Y., Niklaus B., Clement B., and Mansuy D. Microsomal cytochrome P450 dependent oxidation of N-hydroxyguanidines, amidoximes and ketoximes: mechanism of the oxidative cleavage of their C{double bond, long}N(OH) bond with formation of nitrogen oxides. Biochemistry 37 (1998) 17179-17191
11. w-hydroxy-l-arginine as an intermediate. J. Biol. Chem. 268 (1993) 14781-14787
12. Kuneš J., Hojná S., Kadlecová M., Dobešová Z., Rauchová H., Vokurková M., Loukotová J., Pecháňová O., and Zicha J. Altered balance of vasoactive systems in experimental hypertension: the role of relative NO deficiency. Physiol. Res. 53 Suppl. 1 (2004) S23-S34
13. Li H., and Forstermann U. Nitric oxide in the pathogenesis of vascular disease. J. Pathol. 190 (2000) 244-254
14. Mansuy D., and Boucher J.L. Oxidation of N-hydroxyguanidines by cytochromes P450 and NO-synthases and formation of nitric oxide. Drug Metab. Rev. 34 (2002) 593-606
15. Marletta M.A. Nitric oxide synthase: aspects concerning structure and catalysis. Cell 78 (1994) 927-930
16. Maxwell A.J. Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases. Nitric Oxide 6 (2002) 101-124
17. Minami N., Imai Y., Hashimoto J., and Abe K. Contribution of vascular nitric oxide to basal blood pressure in conscious spontaneously hypertensive rats and normotensive Wistar Kyoto rats. Clin. Sci. (Lond) 89 (1995) 177-182
18. Morgan D.J. Permeability of myocardial capillaries to hydrophilic drugs: the paracellular pathway. Clin. Exp. Pharmacol. Physiol. 23 (1996) 975-979
19. OECD, Paris, 1981. Test Guideline 107. Decision of Council C (81) 30 final.
20. Peters Jr. T. All about Albumin (1996), Accademic Press, New York
21. w-hydroxy-l-arginine to citrulline and nitrogen oxides and occurrences in NO synthases of a sequence very similar to the heme binding sequence in P450s. Biochem. Biophys. Res. Commun. 192 (1993) 53-60
22. Stuehr D.J. Structure-function aspects in the nitric oxide synthases. Annu. Rev. Pharmacol. Toxicol. 37 (1997) 339-359
23. w-hydroxy-l-arginine is an intermediate in the biosynthesis of nitric oxide from l-arginine. J. Biol. Chem. 266 (1991) 6259-6263
24. w-hydroxy-l-arginine and other compounds bearing a C{double bond, long}NOH function in the rat aorta. J. Pharmacol. Exp. Ther. 303 (2002) 823-830
25. Zicha J., Dobešová Z., and Kuneš J. Relative deficiency of nitric oxide-dependent vasodilation in salt hypertensive Dahl rats: the possible role of superoxide anions. J. Hypertens. 19 (2001) 247-254
26. Zhou Z.-H., Deng H.-W., and Li Y.-J. The depressor effect of nitroglycerin is mediated by calcitonin gene-related peptide. Life Sci. 69 (2001) 1313-1320